REVIEW
Pituitary tumors in patients with MEN1 syndrome
Luis V. SyroI,
, Bernd W. Scheithauer (in memoriam)II, Kalman KovacsIII, Rodrigo A. ToledoIV, Francisco J. LondoñoV, Leon D. OrtizVI, Fabio RotondoIII, Eva HorvathIII, Humberto UribeVII
Corresponding author
I Department of Neurosurgery, Hospital Pablo Tobon Uribe and Clinica Medellin, Medellin, Colombia.
II Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
III Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
IV Endocrine Genetics Unit (LIM25), Endocrinology, Hospital das Clínicas, University of Sao Paulo School of Medicine, Sao Paulo/SP, Brazil.
V Department of Neurosurgery, Universidad de Antioquia, Hospital San Vicente de Paul, Medellin, Colombia.
VI Division of Neuro-oncology, Instituto de Cancerologia, Clinica Las Americas, Medellin, Colombia.
VII Department of Neurosurgery, Clinica SOMA, Medellin, Colombia.
Read
2434
Timeswas read the article
1118
Total PDF
1316
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 53 | 38 | 91 |
| 2025 11 | 269 | 226 | 495 |
| 2025 10 | 173 | 190 | 363 |
| 2025 9 | 148 | 78 | 226 |
| 2025 8 | 132 | 35 | 167 |
| 2025 7 | 120 | 45 | 165 |
| 2025 6 | 27 | 12 | 39 |
| 2025 5 | 27 | 14 | 41 |
| 2025 4 | 37 | 11 | 48 |
| 2025 3 | 14 | 13 | 27 |
| 2025 2 | 11 | 3 | 14 |
| 2025 1 | 16 | 9 | 25 |
| 2024 12 | 11 | 4 | 15 |
| 2024 11 | 39 | 17 | 56 |
| 2024 10 | 23 | 39 | 62 |
| 2024 9 | 13 | 36 | 49 |
| 2024 8 | 21 | 25 | 46 |
| 2024 7 | 15 | 24 | 39 |
| 2024 6 | 14 | 38 | 52 |
| 2024 5 | 13 | 17 | 30 |
| 2024 4 | 14 | 26 | 40 |
| 2024 3 | 14 | 23 | 37 |
| 2024 2 | 17 | 14 | 31 |
| 2024 1 | 10 | 14 | 24 |
| 2023 12 | 8 | 21 | 29 |
| 2023 11 | 14 | 22 | 36 |
| 2023 10 | 12 | 30 | 42 |
| 2023 9 | 14 | 25 | 39 |
| 2023 8 | 9 | 10 | 19 |
| 2023 7 | 11 | 32 | 43 |
| 2023 6 | 11 | 25 | 36 |
| 2023 4 | 2 | 1 | 3 |
| 2023 3 | 1 | 0 | 1 |
| 2023 1 | 1 | 0 | 1 |
| 2022 12 | 2 | 1 | 3 |
Show all